Reyataz 300 mg hard capsules
- Licence status
- Active substances
- Atazanavir sulfate
- Dosage Form
- Capsule, hard
- Licence number
- EU/1/03/267/8-9
- Licence holder
- Bristol-Myers Squibb Pharma EEIG
Product documents
Licence information
- ATC code
- J05AE Protease inhibitors, J05AE08 atazanavir
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 17/04/2008